Identification and SAR of potent and selective non-peptide obeline somatostatin sst1 receptor antagonists

被引：7

作者：

Troxler, Thomas ^{[1
]}

Hoyer, Daniel ^{[1
]}

Langenegger, Daniel ^{[1
]}

Neumann, Peter ^{[1
]}

Pfaeffli, Paul ^{[1
]}

Sehoeffter, Philippe ^{[1
]}

Sorg, Dieter ^{[1
]}

Swoboda, Robert ^{[1
]}

Hurth, Konstanze ^{[1
]}

机构：

[1] Novartis Inst Biomed Res, CH-4002 Basel, Switzerland

来源：

BIOORGANIC & MEDICINAL CHEMISTRY LETTERS | 2007年 / 17卷 / 14期

关键词：

somatostatin sst(1) receptor antagonists; octa-hydrobenzo[g]quinolines (obelines);

D O I：

10.1016/j.bmcl.2007.04.086

中图分类号：

R914 [药物化学];

学科分类号：

100701 ;

摘要：

A novel class of non-peptide somatostatin receptor ligands bearing the octahydrobenzo[g]quinoline (obeline) structural element has been identified. SAR studies have been performed that led to the discovery of derivatives with high affinity (pK(d) r sst(I) >= 9) and selectivity (>= 150-fold for h sst(1) over h sst(2)-h sst(5)) for somatostatin receptor subtype sst(1). In a functional assay, the compounds act as antagonists at human recombinant sst, receptors. (C) 2007 Elsevier Ltd. All rights reserved.

引用

页码：3983 / 3987

页数：5

共 50 条

[21] Preparation of non-peptide, highly potent and selective antagonists of arginine vasopressin v1A receptor by introduction of alkoxy groups
Shimada, Y
Taniguchi, N
Matsuhisa, A
Yatsu, T
Tahara, A
Tanaka, A
CHEMICAL & PHARMACEUTICAL BULLETIN, 2003, 51 (09) : 1075 - 1080
[22] Subtype selective interactions of somatostatin and somatostatin analogs with sst1, sst2, and sst5 in BON-1 cells
Eva Ludvigsen
Mats Stridsberg
John E. Taylor
Michael D. Culler
Kjell Öberg
Eva T. Janson
Medical Oncology, 2004, 21 : 285 - 295
[23] Non-peptide angiotensin II receptor antagonists
Takeda Chemical Industries, Ltd, Osaka, Japan
Yuki Gosei Kagaku Kyokaishi, 9 (802-810):
[24] Subtype selective interactions of somatostatin and somatostatin analogs with sst1, sst2, and sst5 in BON-1 cells
Ludvigsen, E
Stridsberg, M
Taylor, JE
Culler, MD
Öberg, K
Janson, ET
MEDICAL ONCOLOGY, 2004, 21 (03) : 285 - 295
[25] Discovery and sar of the first non-peptide competitive human glucagon receptor antagonists.
Madsen, P
Knudsen, LB
Wiberg, FC
Carr, RD
ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 1998, 216 : U259 - U259
[26] Advances in non-peptide glucagon receptor antagonists
Madsen, P
Brand, CL
Holst, JJ
Knudsen, LB
CURRENT PHARMACEUTICAL DESIGN, 1999, 5 (09) : 683 - 691
[27] Potent and selective non-peptide human somatostatin receptor subtype-2 (hSSTR-2) agonists.
Yang, LH
Guo, LQ
Pasternak, A
Pan, YP
Berk, S
Degrado, S
Mosley, R
Rohrer, S
Birzin, E
Foor, F
Cheng, K
Schaeffer, J
Chapman, K
Patchett, AA
ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 1998, 216 : U259 - U260
[28] Immunohistochemical localization of somatostatin receptor subtypes sst1 and sst2 in the rat retina
Helboe, L
Moller, M
INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 1999, 40 (10) : 2376 - 2382
[29] Decahydroisoquinoline derivatives as novel non-peptidic, potent and subtype-selective somatostatin sst3 receptor antagonists
Troxler, Thomas
Hurth, Konstanze
Schuh, Karl-Heinrich
Schoeffter, Philippe
Langenegger, Daniel
Enz, Albert
Hoyer, Daniel
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2010, 20 (05) : 1728 - 1734
[30] Synthesis and sar of CCR1-specific non-peptide antagonists.
Islam, I
May, K
Bauman, J
Ghannam, A
Ng, HP
Monahan, S
Wei, GP
Xu, W
Liang, M
Dunning, L
Subramanyam, B
Shen, J
Walters, J
Ho, E
Horuk, R
ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2002, 224 : U65 - U65

← 1 2 3 4 5 →